Lexicon Pharmaceuticals
LXRX
#6174
Rank
โ‚ฌ0.91 B
Marketcap
2,05ย โ‚ฌ
Share price
0.64%
Change (1 day)
95.31%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2025 (TTM): -โ‚ฌ63.95 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are โ‚ฌ70.86 Million. In 2024 the company made an earning of -โ‚ฌ0.18 Billion a decrease over its 2023 earnings that were of -โ‚ฌ0.16 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ63.95 Million-63.57%
2024 -โ‚ฌ0.18 Billion13.15%
2023 -โ‚ฌ0.16 Billion73.74%
2022 -โ‚ฌ89.31 Million16.16%
2021 -โ‚ฌ76.88 Million49.82%
2020 -โ‚ฌ51.32 Million-147.19%
2019 โ‚ฌ0.10 B-203.42%
2018 -โ‚ฌ0.11 Billion-15.31%
2017 -โ‚ฌ0.13 Billion0.2%
2016 -โ‚ฌ0.13 Billion2920.7%
2015 -โ‚ฌ4.11 Million-95.33%
2014 -โ‚ฌ87.92 Million-3.61%
2013 -โ‚ฌ91.22 Million-5.52%
2012 -โ‚ฌ96.55 Million-4.17%
2011 -โ‚ฌ0.11 Billion15.5%
2010 -โ‚ฌ87.24 Million8.36%
2009 -โ‚ฌ80.5 Million-4.81%
2008 -โ‚ฌ84.57 Million28.79%
2007 -โ‚ฌ65.66 Million35.71%
2006 -โ‚ฌ48.39 Million52.91%
2005 -โ‚ฌ31.65 Million-23.89%
2004 -โ‚ฌ41.57 Million-24.19%
2003 -โ‚ฌ54.84 Million-0.48%
2002 -โ‚ฌ55.1 Million44.12%
2001 -โ‚ฌ38.23 Million23.01%
2000 -โ‚ฌ31.08 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
โ‚ฌ6.50 B-10,922.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
โ‚ฌ1.01 B-1,791.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
โ‚ฌ4.51 B-7,619.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-โ‚ฌ0.48 Billion 682.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
โ‚ฌ0.14 B-338.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-โ‚ฌ24.04 Million-59.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-โ‚ฌ20.36 Million-66.11%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚ฌ0.33 B-662.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-โ‚ฌ8.32 Million-86.16%๐Ÿ‡บ๐Ÿ‡ธ USA